PTAB Declines to Institute IPR of Two Patents Challenged by The Coalition for Affordable Drugs

Aug 28, 2015

Reading Time : 1 min

The coalition alleged several grounds of obviousness, each ground based on at least one alleged prior art poster presentation. The coalition argued that the posters were prior art based on statements made by the applicants in information disclosure statements submitted during prosecution of the patents. Acorda filed a preliminary response. In its response Acorda first alleged that the coalition filed its petition for an improper purpose. Acorda then argued, inter alia, the coalition failed to establish that the poster presentations were prior art.

The PTAB did not discuss Acorda’s allegation that the Coalition filed the petitions for an improper purpose. Instead, the PTAB analyzed whether the Coalition had made a threshold showing that the posters were “printed publications.” The PTAB first explained that submission of an IDS does not constitute an admission that a reference is prior art. The PTAB then explained that the Coalition had failed to introduce sufficient evidence related to the amount of time the poster was displayed, the expertise of the audience, or whether there was an expectation that anyone copied the poster. The PTAB also noted that the poster presented very dense material, and the more complex the material, the more difficult it would have been for members of the public to capture the material. At bottom, the PTAB held that the coalition had failed to introduce sufficient evidence that the references were prior art, and declined to institute review. The PTAB left for another day consideration of whether such petitions were filed for an improper purpose.

Coalition for Affordable Drugs (ADROCA) LLC v. Acorda Therapeutics, Inc., IPR2015­00817, IPR2015­00720 (PTAB Aug. 24, 2015).

Share This Insight

Previous Entries

IP Newsflash

February 24, 2026

The Southern District of Florida recently dismissed a complaint without prejudice because the allegations used a form of “shotgun pleading.” The court explained that a shotgun pleading includes those where every count incorporates every preceding paragraph into each cause of action, and that dismissal of such pleadings was required under Eleventh Circuit precedent.

...

Read More

IP Newsflash

February 20, 2026

The Federal Circuit recently addressed whether the PTO must conduct notice‑and‑comment rulemaking before issuing instructions that guide how the Board should exercise discretion at the institution stage of IPRs. The court held that no such rulemaking is required. Instructions to the Board regarding its use of the Director’s delegated discretionary authority not to institute review are merely general statements of policy exempt from notice-and-comment rulemaking.  

...

Read More

IP Newsflash

February 18, 2026

The District Court for the District of Delaware recently invalidated claims directed to a panoramic objective lens for lack of enablement, holding the claims impermissibly recited a single element in means‑plus‑function form. Under § 112, ¶ 6, “[a]n element in a claim for a combination may be expressed as a means or step for performing a specified function….” By its plain terms, the statute permits means‑plus‑function claiming only in the context of a “combination.” In other words, a claim may not consist solely of a single means‑plus‑function element. Claims drafted as a single means are invalid for lack of enablement as a matter of law.

...

Read More

IP Newsflash

February 13, 2026

In an ANDA litigation, the District of Delaware recently denied the defendants’ motion to compel the production of correspondence between the plaintiffs’ testifying expert and a third-party analyst who had performed experiments and provided data used by the testifying expert. The court found that the scope of material sought by the motion was overbroad and disproportionate to the needs of the case.

...

Read More

© 2026 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.